PDF 原檔:報告_MS_信驊5274_20261007_original.pdf
圖片清單(已驗證 2026-10-09)
| 檔名 | size | 分類 | 親眼所見內容 |
|---|---|---|---|
報告_MS_信驊5274_20261007_001.png |
65KB | 真資料圖 | 目標價(紅色虛線階梯,終點標示 24000)vs 股價(藍色線)歷史走勢圖,2023-10 至 2026-10,另標註歷次 O/A、E/I、O/I 評等變動點 |
原始內容
Aspeed Technology | Asia Pacific
Emerging competition from Marvell?
Marvell, at its Investor Day on October 6, 2026, unveiled a new semi-custom Al infrastructure management processor based on its 5nm OCTEON IP, tar etin workloads that the company said offered ~1,000x more performance than traditional server BMCs (baseboard mana ement controllers). Importantly, Marvell (covered by Joe Moore) said it already has pro rams with multiple hyperscalers.
Our preliminary view - We see this as more new TAM than direct competition for Aspeed in the near term. 1) We view this as IMC (infrastructure mana ement controller) (not BMC), with ASP of a few hundred US dollars and some volume from end of 2027 or early 2028. 2) Potentially a few clusters or a few racks will need one IMC. 3) Even if customers want to replace BMC with IMC directly, the whole rack architecture would need to be redesi ned, which we think is unlikely to happen in the near term.
| Morgan Stanley Taiwan Limited+ | Morgan Stanley Taiwan Limited+ | Morgan Stanley Taiwan Limited+ | Morgan Stanley Taiwan Limited+ |
|---|---|---|---|
| Daniel Yen, CFA | Daniel Yen, CFA | Daniel Yen, CFA | Daniel Yen, CFA |
| Equity Analyst Dani l.Y n@morganstanl y.com | Equity Analyst Dani l.Y n@morganstanl y.com | Equity Analyst Dani l.Y n@morganstanl y.com | +886 2 2730-2863 |
| Charlie Chan | Charlie Chan | Charlie Chan | |
| Equity Analyst | Equity Analyst | Equity Analyst | |
| Charli .Chan@morganstanl y.com | Charli .Chan@morganstanl y.com | Charli .Chan@morganstanl y.com | +886 2 2730-1725 |
| Morgan Stanley Asia Limited+ | Morgan Stanley Asia Limited+ | Morgan Stanley Asia Limited+ | |
| Daisy Dai, CFA | Daisy Dai, CFA | Daisy Dai, CFA | |
| Equity Analyst Daisy.Dai@morganstanl y.com | Equity Analyst Daisy.Dai@morganstanl y.com | Equity Analyst Daisy.Dai@morganstanl y.com | +852 2848-7310 |
| Morgan Stanley Taiwan Limited+ | Morgan Stanley Taiwan Limited+ | Morgan Stanley Taiwan Limited+ | |
| Lucas Wan | Lucas Wan | Lucas Wan | |
| R s arch Associat | R s arch Associat | R s arch Associat | |
| Lucas.Wang@morganstanl y.com | Lucas.Wang@morganstanl y.com | Lucas.Wang@morganstanl y.com | +886 2 2730-2875 |
| Morgan Stanley Asia Limited+ | Morgan Stanley Asia Limited+ | Morgan Stanley Asia Limited+ | |
| Ethan Jia | Ethan Jia | Ethan Jia | |
| R s arch Associat | R s arch Associat | R s arch Associat | |
| Ethan.Jia@morganstanl y.com | Ethan.Jia@morganstanl y.com | Ethan.Jia@morganstanl y.com | +852 3963-2287 |
| Henry Zhao | Henry Zhao | Henry Zhao | |
| Equity Analyst H nry.Zhao@morganstanl y.com | Equity Analyst H nry.Zhao@morganstanl y.com | Equity Analyst H nry.Zhao@morganstanl y.com | +852 2239-7731 |
| Aspeed Technology(5274.TWO, 5274 TT) | Aspeed Technology(5274.TWO, 5274 TT) | Aspeed Technology(5274.TWO, 5274 TT) | |
| Greater China Technology Semiconductors | Greater China Technology Semiconductors | Greater China Technology Semiconductors | | Taiwan Overweight |
| Stock Rating Industry View | Stock Rating Industry View | Stock Rating Industry View | Attractive NT$24,000.00 |
| Price target | Price target | Price target | 26 |
| Up/downside to price target (%) S r price, close (Oct 6, 2026) | Up/downside to price target (%) S r price, close (Oct 6, 2026) | Up/downside to price target (%) S r price, close (Oct 6, 2026) | |
| 52-Week Range | 52-Week Range | 52-Week Range | NT$18,985.00 |
| NT$21,800.00- 4,645.46 | |||
| 38 | |||
| S out, dil, curr (mn) | S out, dil, curr (mn) | S out, dil, curr (mn) | NT$712,963 |
| Mkt cap, curr (mn) EV, curr (mn) | Mkt cap, curr (mn) EV, curr (mn) | Mkt cap, curr (mn) EV, curr (mn) | NT$706,664 |
| Avg daily trading value (mn) | Avg daily trading value (mn) | Avg daily trading value (mn) | |
| NT$3,980 | |||
| Fiscal Year Ending | 12/25 | 12/26e | 12/27e 12/28e |
| EPS (NT$)** | 103.94 | 207.93 | 313.49 443.53 |
| Prior EPS (NT$)** EPS (NT$)§ | - 100.67 | - 198.52 | - - 342.30 478.65 |
| Revenue, net (NT$ mn) | 9,085 | 18,702 | 29,808 40,761 |
| EBITDA (NT$ mn) | 4,984 | 10,584 | 17,475 24,792 |
| ModelWare net inc (NT | 3,928 | 8,882 | 20,288 |
| $ mn) 14,340 | $ mn) 14,340 | $ mn) 14,340 | $ mn) 14,340 |
| P/E | 63.5 | 91.3 | 60.6 42.8 |
| P/BV | 32.7 | 54.1 | 34.0 22.7 |
| RNOA (%) | 214.7 | 623.8 | 468.4 416.7 |
| ROE (%) | 69.7 | 117.3 | 108.8 96.8 |
| EV/EBITDA | 66.4 | 39.9 27.7 | |
| 48.5 | 2.0 | ||
| Div yld (%) | 0.5 | 0.9 | 1.4 |
Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investment decision.
For analyst certification and other important disclosures, refer to the Disclosure Section, located at the end of this report.
= Analysts employed by non-U.S. affiliates are not registered with FINRA, may not be associated persons of the member and may not be subject to FINRA restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account.
FCF yld ratio (%)** Leverage (EOP) (%)
0.6
0.9
1.5
2.1
(83.2) (78.8) (78.7) (80.4)
Unless ot erwise noted, all metrics are based on Morgan Stanley ModelWare framework
** = Based on consensus met odology
§ = Consensus data is provided by Refinitiv Estimates
e = Morgan Stanley Researc estimates M Update
Valuation Methodology and Risks
Aspeed Technology (5274.TWO)
Base case, residual income model. Key assumptions:
- n Cost of equity of 9.8% (2.0% risk-free rate, 6% risk premium, 1.3 beta)
- nMedium-term rowth rate of 21.4%
- n Terminal rowth rate of 5.5%
- n Cash payout ratio of 85%
Risks to Upside
- n Stron er cloud demand
- n Faster-than-expected spec mi ration
- nMild competition
Risks to Downside
- n Softenin cloud demand
- n Slower-than-expected spec mi ration
- n Intensified competition
- n Further policy ti htenin in China
M Update
Disclosu e Section
The information and opinions in Morgan Stanley Research were prepared or are disseminated by Morgan Stanley Asia Limited (which accepts the responsibility for its contents) and or Morgan Stanley Asia (Singapore) Pte. (Registration number 199206298Z) and or Morgan Stanley Asia (Singapore) Securities Pte Ltd (Registration number 200008434H), regulated by the Monetary Authority of Singapore (which accepts legal responsibility for its contents and should be contacted with respect to any matters arising from, or in connection with, Morgan Stanley Research), and or Morgan Stanley Taiwan Limited and or Morgan Stanley & Co International plc, Seoul Branch, and or Morgan Stanley Australia Limited (A.B.N. 67 003 734 576, holder of Australian financial services license No. 233742, which accepts responsibility for its contents), and or Morgan Stanley Wealth Management Australia Pty Ltd (A.B.N. 19 009 145 555, holder of Australian financial services license No. 240813, which accepts responsibility for its contents), and or Morgan Stanley India Company Private Limited having Corporate Identification No (CIN) U22990MH1998PTC115305, regulated by the Securities and Exchange Board of India ('SEBI') and holder of licenses as a Research Analyst (SEBI Registration No. INH000001105); Stock Broker (SEBI Stock Broker Registration No. INZ000244438), Merchant Banker (SEBI Registration No. INM000011203), and depository participant with National Securities Depository Limited (SEBI Registration No. IN-DP-NSDL-567-2021) having registered office at Altimus, Level 39 & 40, Pandurang Budhkar Marg, Worli, Mumbai 400018, India; Telephone no. +91-22-61181000; Compliance Officer Details: Mr. Tejarshi Hardas, Tel. No.: +91-22-61181000 or Email: tejarshi.hardas@morganstanley.com; Grievance officer details: Mr. Tejarshi Hardas, Tel. No.: +91-22-61181000 or Email: msic-compliance@morganstanley.com which accepts the responsibility for its contents and should be contacted with respect to any matters arising from, or in connection with, Morgan Stanley Research, and their affiliates (collectively, "Morgan Stanley"). Morgan Stanley India Company Private Limited (MSICPL) may use AI tools in providing research services. All recommendations contained herein are made by the duly qualified research analysts.
For important disclosures, stock price charts and equity rating histories regarding companies that are the subject of this report, please see the Morgan Stanley Research Disclosure Website at www.morganstanley.com eqr disclosures webapp generalresearch, or contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY, 10036 USA.
For valuation methodology and risks associated with any recommendation, rating or price target referenced in this research report, please contact the Client Support Team as follows: US Canada +1 800 303-2495; Hong Kong +852 2848-5999; Latin America +1 718 754-5444 (U.S.); London +44 (0)20-7425-8169; Singapore +65 6834-6860; Sydney +61 (0)2-9770-1505; Tokyo +81 (0)3-6836-9000. Alternatively you may contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY 10036 USA.